期刊文献+

黄芪总苷对TGF-β1诱导下足细胞TRPC6表达的影响 被引量:7

Effects of astragaloside on TRPC6 expression on mouse podocyte induced by TGF-β1
暂未订购
导出
摘要 目的:通过观察黄芪总苷对TGF-β1诱导足细胞TRPC6表达的影响,探讨黄芪总苷对足细胞保护作用。方法:体外培养小鼠肾小球足细胞,将成熟的足细胞分为5组:正常对照组、TGF-β1干预组、TGF-β1干预+低剂量黄芪总苷组、TGF-β1干预+中剂量黄芪总苷组、TGF-β1干预+高剂量黄芪总苷组,48 h后MTT检测各组细胞增殖抑制率,Western blot及RT-PCR检测TRPC6蛋白及mRNA表达水平。结果:TGF-β1干预使足细胞足突回缩、甚至消失,抑制足细胞的增殖(P<0.05),提高TRPC6mRNA和蛋白表达(P<0.05),黄芪总苷能逆转上述变化,对足细胞具有保护作用并且存在一定的量效关系。结论:TPRC6在TGF-β1干预下足细胞损伤作用中起重要作用,黄芪总苷可能通过下调足细胞TRPC6的表达实现对足细胞的保护作用。 Objective: To explore the possible mechanism of astragaloside involved in the mouse podocytes injury induced by TGF-β1 in vitro. Methods: Mouse podocytes were cultured in vitro and then all cell were divided into 5 groups: normal control group,TGF-β1 treatment group,TGF-β1 treatment +astragaloside low dose group,TGF-β1 treatment +astragaloside middle dose group and TGF-β1 treatment +astragaloside high dose group. The proliferation rate of each group was investigated by MTT assay,the expression of TRPC6 protein and mRNA were measured by Western blot and RT-PCR respectively after 48 hours. Results: TGF-β1 can significantly inhibit the proliferation of podocytes( P〈0. 05),fusions of foot processes or even effaced of podocytes were observed. TGF-β1 could also increase the expression of TRPC6. Astragaloside could reduce the inhibition of TGF-β1 to the proliferain of podocytes significantly,make the cell shape tend to be normal,and reduce the expression of TRPC6 mRNA and protein with dose-effect relation. Conclusion: TRPC6 play an important role in the TGF-β1 induecd podocytes injury. Astragaloside can alleviate podocytes injury by reduce the expression of TRPC6.
作者 黄海庭 吴好好 覃幼玲 林栩 尤燕舞 郭鹏威 汤春荣 HUANG Hai-Ting WU Hao-Hao QIN You-Ling LIN Xu YOU Yan-Wu GUO Peng-Wei TANG Chun-Rong(Department of Nephrology, the Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, Chin)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2017年第3期370-373,共4页 Chinese Journal of Immunology
基金 广西自然科学基金(2014GXNSFAA118269)
关键词 足细胞 转化生长因子-Β1 TRPC6 黄芪总苷 Podocytes TGF-β1 TRPC6 AST
  • 相关文献

参考文献3

二级参考文献20

  • 1Li JJ, Kwak SJ, Jung DS, et al. Podocyte biology in diabetic nephropathy[J]. Kidney Int Suppl, 2007, 106:S36-S42.
  • 2Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy[J]. Clin Sci (Lond), 2013, 124: 139-152.
  • 3Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint[J]. Kidney Int, 2008, 74: 22-36.
  • 4Wang G, Lai FM, Lai KB, et al. Urinary messenger RNA expression of podocyte- associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker[J]. Eur J Endoerinol,2008, 158: 317-322.
  • 5Cheng J, Zhang W, Zhang X, et al. Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis [J]. Clin J Am Soc Nephrol, 2012, 7: 391-400.
  • 6Deb DK, Sun T, Wong KE, et al. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes[J]. Kidney Int, 2010, 77: 1000-1009.
  • 7He W, Kang YS, Dai C, et al. Blockade of Wnt/beta- catenin signaling by paricalcitol ameliorates proteinuria and kidney injury[J]. J Am Soc Nephrol, 2011, 22: 90-103.
  • 8Deb DK, Chen Y, Zhang Z, et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF- {kappa}B pathway[J]. Am J Physiol Renal Physiol, 2009, 296: F1212-F1218.
  • 9Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair[J], J Clin Invest, 2008, 118: 3522-3530.
  • 10Eardley KS, Zehnder D, Quinkler M, et al. The relationship between albuminuria, MCP - 1/CCL2, and interstitial macrophages in chronic kidney disease[J]. Kidney Int, 2006, 69: 1189-1197.

共引文献84

同被引文献106

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部